Percutaneous Saphenous Vein Graft Intervention-A Review

Heart Lung and Circulation

Volumn 16, Issue SUPPL. 3, 2007, Pages

  Hiscock, Martin ^a   Oqueli, Ernesto ^a   Dick, Ron ^a  

^a EPWORTH HOSPITAL   (Australia)

Author keywords

Distal embolisation; Embolic protection devices; Percutaneous intervention; Saphenous vein graft

Indexed keywords

ADENOSINE; FIBRINOGEN RECEPTOR ANTAGONIST; METAL; NITROPRUSSIDE SODIUM; PACLITAXEL; POLITEF; RAPAMYCIN; VERAPAMIL;

CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEATH; DISEASE COURSE; DRUG ELUTING STENT; EQUIPMENT DESIGN; GRAFT OCCLUSION; GRAFT PATENCY; GRAFT SURVIVAL; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; RECURRENCE RISK; REOPERATION; REVIEW; RISK ASSESSMENT; SAPHENOUS VEIN GRAFT; SURGICAL EQUIPMENT; THROMBECTOMY; TREATMENT OUTCOME; VEIN GRAFT DISEASE;

ANGIOPLASTY, BALLOON; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; EMBOLIZATION, THERAPEUTIC; HUMANS; SAPHENOUS VEIN;

EID: 34547807546     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2007.03.016     Document Type: Review

References (30)

1. Campeau L., Lesperance J., Hermann J., Corbara F., Grondin C.M., and Bourassa M.G. Loss of improvement of angina between 1 and 7 years after aortocoronary bypass surgery. Circulation 60 (1979) 1-5
2. Fitzgibbon G.M., Leach A.J., Kafka H.P., Keon W.J., Hooper G.D., and Burton J.R. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5065 grafts related and reoperation in 1388 patients during 25 years. J Am Coll Cardiol 28 (1996) 616-626
3. Cameron A., Kemp Jr. H.G., and Green G.E. Reoperation for coronary artery disease: 10 years of clinical follow-up. Circulation 78 (1998) 1158-1162
4. Le May M., Labinaz M., Marquis J.F., Laramee L.A., O'Brien E.R., Williams W.L., Jelley J.L., Woodend K., and Higginson L.A. Predictors of long-term outcome after stent implantation in a saphenous vein graft. Am J Cardiol 83-85 (1999) 681-686
5. de Feyter P., van Suylen R.J., de Jaegere P.J., Topol E.J., and Serruys P.W.J.C. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J Am Coll Cardiol 2 (1993) 1539-1549
6. Hanekamp C., Koolen J., den Heijer P., Schalij M., Piek J., Bär F., de Scheerder I., Bonnier H., Pijls N., and VENESTENT Study Group. A randomised comparison between balloon angioplasty and elective stent implantation in venous bypass grafts; the VENESTENT study. Cathet Cardiovasc Interv 60 (2003) 452-457
7. Savage M.P., Douglas Jr. J.S., Fischman D.L., Pepine C.J., King III S.B., Werner J.A., Bailey S.R., Overlie P.A., Fenton S.H., Brinker J.A., Leon M.B., Goldberg S., and for the Saphenous Vein De Novo Trial Investigators. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 337 (1997) 740-747
8. Silber S., Albertsson P., Aviles F.F., Camici P.G., Colombo A., Hamm C., Jorgensen E., Marco J., Nordrehaug J.E., Ruzyllo W., Urban P., Stone G.W., and Wijns W. Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions: the task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J 26 (2005) 804-847
9. Vermeersch P., Agostini P., Verheye S., van den Heuvel P., Convens C., Bruining N., van den Branden F., and van Langenhove G. Randomised double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six month angiographic, intravascular ultrasound and clinical follow-up of the RRISC Trial. J Am Coll Cardiol 48 12 (2006) 2423-2431
10. Ge L., Iakovou I., Sangiorgi G.M., Chieffo A., Melzi G., Cosgrave J., Montorfano M., Michev I., Airoldi F., Carlino M., Corvaja N., and Colombo A. Treatment of saphenous vein graft lesions with drug-eluting stents. J Am Coll Cardiol 45 (2005) 989-994
11. Lee M.S., Shah A.P., Aragon J., Jamali A., Dohad S., Kar S., and Makkar R.R. Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts. Cathet Cardiovasc Interv 66 (2005) 507-511
12. Kereiakes D.J., Kuntz R.E., Mauri L., and Krucoff M.W. Surrogates, sub-studies and real clinical end points in trials of drug-eluting stents. J Am Coll Cardiol 45 (2005) 1206-1212
13. Chu W., Kuchulakanti P., Wang B., Clavijo L., Suddath W., Pichard A., Satler L., Kent K., and Waksman R. Efficacy of sirolimus-eluting stents as compared to paclitaxel-eluting stents for saphenous vein graft intervention. J Interv Cardiol 19 2 (2006) 121-125
14. Baldus S., Köster R., Elsner M., Walter D.H., Arnold R., Auch-Schwelk W., Berger J., Rau M., Meinertz T., Zeiher A.M., and Hamm C.W. Treatment of aortocoronary vein graft lesion with membrane-covered stents: a multicentre surveillance trial. Circulation 102 (2000) 2024-2027
15. Schachinger V., Hamm C., Munzel T., Haude M., Baldus S., Grube E., Bonzel T., Konorza T., Köster R., Arnold R., Haase J., Probst P., vom Dahl J., Neumann F.-J., Mudra H., Hennen B., Thiele L., Zeiher A.M., and STING (STents IN Grafts) Investigators. A randomised trial of polytetrafluoroethylene membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts. J Am Coll Cardiol 42 (2003) 1360-1369
16. Hong M., Mehran R., Dangas G., Mintz G.S., Lansky A.J., Pichard A.D., Kent K.M., Satler L.F., Stone G.W., and Leon M.B. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 100 (1999) 2400-2405
17. Webb J., Carere R., Virmani R., Baim D., Teirstein P.S., Whitlow P., McQueen C., Kolodgie F.D., Buller E., Dodek A., Mancini G.B., and Oesterle S. Retrieval and analysis of particulate debris after saphenous vein graft intervention. J Am Coll Cardiol 34 2 (1999) 468-475
18. Leopold J., Berger C., and Cupples L. No-reflow during coronary intervention: observations and implications. Circulation 102 (2000) II-644
19. Sdringola S., Assali A., Ghani M., Moustapha A., Achour H., Yusuf S.W., Fujise K., Rosales O., Schroth G.W., Anderson H.V., and Smalling R.W. Risk assessment of slow or no re-flow phenomenon in aortocoronary vein graft percutaneous intervention. Cathet Cardiovasc Interv 54 3 (2001) 318-324
20. Sdringola S., Assali A., Ghani M., Yepes A., Rosales O., Schroth G.W., Fujise K., Anderson H.V., and Smalling R.W. Adenosine use during aortocoronary vein graft interventions reverses but does not prevent the slow/no re-flow phenomenon. Cathet Cardiovasc Diagn 51 4 (2000) 394-399
21. Kern M. Adenosine boluses: a cure for "no-reflow"?. Cathet Cardiovasc Diagn 45 4 (1998) 366-367
22. Ellis S., Linkoff A., Miller D., Tcheng J.E., Kleiman N.S., Kereiakes D., Califf R., and Topol E.J. Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. J Am Coll Cardiol 32 (1998) 1619-1623
23. Mathew V., Grill D., Scott C., Grantham A., Ting H.H., Garratt K.N., and Holmes D.R. The influence of abciximab use on clinical outcome after aortocoronary vein graft interventions. J Am Coll Cardiol 34 (1999) 1163-1169
24. Karha J., Gurm H., Rajagopal V., Fathi R., Bavry A.A., Brener S.J., Lincoff A.M., Ellis S.G., and Bhatt D.L. Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes. Am J Cardiol 98 (2006) 906-910
25. Grube E., Schofer J., Webb J., Schuler G., Colombo A., Sievert H., Gerckens U., and Stone G.W. Evaluation of a balloon occlusion and aspiration system for protection from distal embolisation during stenting in saphenous vein grafts. Am J Cardiol 89 (2002) 941-945
26. Baim D., Wahr D., George B., Leon M., Greenberg J., Cutlip D., Kaya U., Popma J.J., Ho K., and Kuntz E. Randomised trial of a distal embolic protection device during percutaneous intervention of saphenous vein aortocoronary bypass grafts. Circulation 105 (2002) 1285-1290
27. Carrozza J., Mumma M., Breall J., Fernandez A., Heyman E., Metzger C., and PRIDE Study Investigators. Randomised evaluation of the TriActiv balloon-protection flush and extraction system for the treatment of saphenous vein graft disease. J Am Coll Cardiol 46 (2005) 1677-1683
28. Stone G., Rogers C., Hermiller J., Feldman R., Hall P., Haber R., Masud A., Cambier P., Caputo R., Turco M., Kovach R., Brodie B., Herrmann H., Kuntz R., Popma J., Ramee S., and Cox D. Randomised comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aortocoronary bypass grafts. Circulation 108 (2003) 548-553
29. Rogers C. A prospective randomised comparison of proximal and distal protection in patients with diseased saphenous vein grafts [abstract]. Presented at transcatheter cardiovascular therapeutics; October 2005.
30. Mauri L., Rogers C., and Baim D. Devices for distal protection during percutaneous coronary revascularisation. Circulation 113 (2006) 2651-2656